NeuRizer Ltd
NeuRizer Ltd operates in the Chemicals industry within the Materials sector, though specific revenue-generating activities are not detailed in the available data.
Business. NeuRizer Ltd (NRZ.AX) is a chemicals company listed on the Australian Securities Exchange. The firm operates within the Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
NeuRizer Ltd (NRZ.AX) is a chemicals company listed on the Australian Securities Exchange. The firm operates within the Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.
NeuRizer Ltd exhibits a capital structure characterized by minimal leverage but severe liquidity constraints. The company holds total assets of AUD 129.3 million against total liabilities of AUD 56.3 million, resulting in total equity of AUD 73.0 million. Long-term debt is negligible at AUD 2.1 million, yielding a debt-to-equity ratio of 0.03. However, the balance sheet shows zero cash and equivalents, and the current ratio stands at 0.01, indicating an inability to cover short-term obligations with current assets. The market capitalization is AUD 3.4 million, trading at a price-to-book ratio of 0.05, suggesting the market values the firm at a significant discount to its tangible book value.
Profitability metrics are deeply negative, reflecting a pre-revenue or early-stage loss-making profile. The company reports an operating income of -AUD 2.6 million and a net income of -AUD 5.6 million. Return on equity is -7.67%, and return on assets is -4.33%. These figures indicate that the company is consuming capital rather than generating returns, with no positive earnings to support valuation multiples such as P/E or EV/EBITDA, the latter of which is negative at -2.11.
- The company trades at a 95% discount to book value (P/B 0.05) with a market cap of AUD 3.4 million.
- Liquidity is critically constrained with a current ratio of 0.01 and zero cash on hand.
- The firm is unprofitable with a net loss of AUD 5.6 million and negative operating cash flow of AUD 3.6 million.
- Leverage is minimal with a debt-to-equity ratio of 0.03, but the lack of cash poses immediate operational risks.
- No historical growth data or segment breakdowns are available to assess business model viability.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income −1,2% YoY; Net income +20,3% YoY.
- ▍Operating income −1,2% YoY
- ▍Net income +20,3% YoY
- ▍Free cash flow −56,7% YoY
Operating income −40,6% YoY; Net income −50,3% YoY.
- ▍Operating income −40,6% YoY
- ▍Net income −50,3% YoY
- ▍Free cash flow −55,3% YoY
Operating income -A$7.0M.
- ▍Operating income -A$7.0M
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Enterprise Valuemarket_cap - net_cash
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- NeuRizer Ltd Market data — financials · 2026-07-14
Ownership & reference
Leadership
- Daniel Justyn Douglas PetersExecutive Chairman of the Board